We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

The New and the Next in Brain Health Biomarkers

By CLN Stat
Posted on 14 Dec 2020
Print article
The Journal of Applied Laboratory Medicine hot topics session spotlights labs’ role in identifying and managing neurodegeneration and brain injury.

Building on the January 2020 special collection issue on brain health biomarkers, this year’s Journal of Applied Laboratory Medicine (JALM) Hot Topics session spotlights new biomarker applications in neurological disease and highlights laboratories’ role in identifying and managing neurodegeneration and brain injury. Knowledge about brain health is growing rapidly, in particular for Alzheimer’s disease and traumatic brain injury (TBI), Robert Christenson, PhD, editor-in-chief of JALM and professor of pathology and professor of medical and research technology at the University of Maryland School of Medicine in Baltimore, told CLN Stat.

Clinical laboratorians and other attendees at the 2020 AACC Annual Scientific Meeting should know and understand the current status and future promise of advances in these fields. “We believed that a session highlighting the information in JALM and recent findings on these fields would be of particular interest,” added Christenson.

Attendees will learn about the strengths and weaknesses of current TBI biomarkers for use at the point-of-care and in central laboratories, summarized co-presenter Mari DeMarco, PhD, DABCC, FCACB, a clinical associate professor in the department of pathology and laboratory medicine at the University of British Columbia. For Alzheimer’s disease biomarkers, attendees will be able to describe case criteria for appropriate use of testing and learn through a series of case presentations how to interpret core biomarkers for diagnosing Alzheimer’s disease and related disorders.

“Moreover, participants will gain an understanding of the current and evolving role of biomarkers in the development of novel therapeutics for neurodegenerative disorders,” added DeMarco.

Biomarker Utilization in Neurological Disease: a JALM Hot Topics Symposium features three presentations.

DeMarco will address cerebrospinal fluid biomarkers for Alzheimer’s disease. These core biomarkers “are recommended by the international community for diagnostics purposes under select circumstances and used in clinical care around the globe,” said DeMarco. “Beyond the core biomarkers, there are biomarkers in both blood and cerebrospinal fluid under investigation for complementary applications, including facilitating clinical trial enrollment—enriching for populations of interest—and monitoring response to therapy.”

Omar Laterza, PhD, DABCC, executive director for molecular biomarkers and diagnostics at Merck, plans to discuss the role of biomarkers in developing therapeutics that target Alzheimer’s and other neurological diseases. Christenson rounds out the session with a talk on the present and future status of TBI biomarkers.

For TBI, the U.S. Food and Drug Administration has cleared an assay as an aid in evaluating concussion. “However, the current platform for measurement is not ideal for rapid turnaround of results,” said Christenson. “Other indications for biomarkers in blood and other fluids are being actively developed.” Additional applications should be available in the near future. For Alzheimer’s disease, some clinical practices are measuring beta-amyloid 42 (major component of amyloid plaques), and tau and phosphorylated tau (major components of tau tangles in the brain).

This Hot Topics scientific session at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo takes place on December 16 from 11 a.m.–12:30 p.m. U.S. Central Standard Time and is worth 1.5 ACCENT credit hours.

Related Links:
2020 AACC Annual Scientific Meeting
Biomarker Utilization in Neurological Disease: a JALM Hot Topics Symposium
Platinum Supplier
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Gold Supplier
Real-Time PCR System
Gentier 96T
Complement 3 (C3) Test
GPP-100 C3 Kit
C. difficile Toxins Test

Print article


Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more


view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more


view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more


view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more


view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more


view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.